Insights on the Dry Eye Syndrome Global Market to 2027 – by Disease Type, Drug Type, Product, Distribution Channel and Region – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global dry eye syndrome market reached a value of US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 6 Billion by 2027, exhibiting a CAGR of 5.95% during 2022-2027. Companies Mentioned Akorn Inc. Alimera Science Allergan plc. Auven Therapeutics Bausch + Lomb Gla